Gut Microbiota-Derived Metabolites Confer Protection against SARS-CoV-2 Infection

Researchers defined multiple pathways by which the gut microbiome protects mammalian hosts from SARS-CoV-2 intranasal infection, both locally and systemically, via production of short-chain fatty acids.